Crispr Therapeutics shares tumble after significant earnings miss
Tuesday, Jefferies reiterated its Buy rating on CyberArk Software (NASDAQ:CYBR) with a price target of $475.00, aligning with the broader analyst consensus that remains strongly bullish. With 15 analysts recently revising earnings estimates upward according to InvestingPro data, the stock’s potential appears compelling despite trading above its Fair Value. Following CyberArk’s Analyst Day in Boston, the firm expressed increased optimism regarding the company’s growth potential in Privileged Access Management (PAM) and its expanding platform capabilities. The areas identified with significant growth opportunities include machine identity, modern Identity Governance Administration (IGA), and agentic AI.
The company’s guidance for 2028 outlines a strategy for achieving an 18% compound annual growth rate (CAGR) in Annual Recurring Revenue (ARR) from 2024 to 2028, aiming to reach $2.3 billion, along with $600 million in free cash flow (FCF). This ambitious target builds on CyberArk’s impressive 33.1% revenue growth over the last twelve months and robust 79.18% gross profit margins. This projection aligns with Jefferies’ confidence in CyberArk’s financial future, particularly their own estimate of $500 million in FCF by 2027, which is 47 times their price target.
CyberArk’s Analyst Day highlighted the company’s focus on machine identity and the broadening of its platform, which includes advancements in agentic AI. These elements support the company’s vision for sustained growth and solidify its position in the cybersecurity sector. The positive market commentary and management’s guidance for 2028 have bolstered Jefferies’ outlook on CyberArk’s stock.
The firm’s price target of $475.00 reflects a belief in the company’s ability to capitalize on the opportunities within the evolving cybersecurity landscape. CyberArk’s strategic plan indicates a robust pathway to increased ARR and FCF, key indicators of the company’s financial health and operational efficiency.
Investors and stakeholders in CyberArk Software can look to the company’s long-term growth framework as a sign of its commitment to expanding its market share and enhancing shareholder value. For deeper insights into CyberArk’s financial health (currently rated as GOOD by InvestingPro) and access to 13 additional ProTips, including detailed valuation metrics and growth indicators, investors can explore the comprehensive Pro Research Report available on the platform. Jefferies’ reiteration of the Buy rating and price target suggests a positive view of CyberArk’s future financial performance.
In other recent news, CyberArk Software has reported impressive financial results, prompting several analysts to adjust their price targets for the company. BofA Securities raised its target to $500, reflecting CyberArk’s strong position in the evolving Identity Security market, with a notable 51% increase in annual recurring revenue (ARR) including the impact of the Venafi acquisition. Similarly, Stifel increased its price target to $444, citing CyberArk’s expanding platform and successful integration of Venafi and Zilla Security. Baird also adjusted its target to $455, highlighting the company’s robust fourth-quarter performance and the strategic significance of its recent acquisitions, particularly in machine identity security and Identity Governance Administration (IGA).
KeyBanc Capital Markets raised its price target to $485 following CyberArk’s strong fourth-quarter results, noting a significant accounts receivable figure that surpassed expectations. The firm’s guidance for 2025 projects a 21% year-over-year growth in ARR, exceeding market consensus. Analysts from Citi maintained a Buy rating with a $410 target, emphasizing CyberArk’s strategic initiatives and the expected growth in Venafi’s SaaS bookings mix. These developments reflect CyberArk’s solid market position and the potential for sustained growth in its cybersecurity offerings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.